Skip to main content
Allo-HSCT plus monoclonal antibody treatment can improve survival in patients with r/r B-ALL
Primary tabs
•••
View
Get Stamp Tags
Published Locations
Breadcrumb
Home
Allo-HSCT plus monoclonal antibody treatment can improve survival in patients with r/r B-ALL
User login
Username
Password
Reset your password
concept
Lead
score
Acute Leukemia
1
1
Specialty
Lead
score
Hematology-Oncology
1
1